VN
EN
Close Menu
Home page
About Us
About Imexpharm
Our Culture
Our Journey
People
Potential
News
Imexpharm News
Events
Specialized
Investor Events
Community Activities
Products
Product Groups
Products A-Z
Investors
Investor events
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Corporate Governance
Search All
Our Charter
Management Regulations
Corporate Governance Reports
Prospectus
Code of Conduct
Community
Careers
Media
Contact
Home
Investors
Investor documents
Information Disclosure
Information Disclosure
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Close Filter
Find report
Search
09/12/2023
IMP - Disclosure: official dispatch of the SSC re. receipt of full documents reporting on stock issuance to pay dividends in 2022 of IMP
08/15/2023
IMP: Resolution of the BOD No. 08/2023/NQ-HĐQT-IMP dated August 14, 2023
08/15/2023
IMP - Resolution of the BOD No. 07/2023/NQ-HĐQT-IMP dated August 14, 2023
07/28/2023
IMP: Report on Corporate Governance for the First 6 months of 2023
07/11/2023
IMP: Resolution of the BOD No.06/2023/NQ-HĐQT-IMP dated July 10, 2023
07/11/2023
IMP - Information disclosure: No. 317 Announcement of audit contract in 2023
05/15/2023
IMP - Information on the number of members nominated and running for the position of member of the BOD of IMP for the 2023-2027 term
04/29/2023
IMP - Information disclosure: Internal regulations on corporate governance approved by the AGM on April 28, 2023
04/29/2023
IMP - Resolution of the BOD at the 1st meeting for the term of 2023-2027
View document
04/29/2023
IMP - Information disclosure: Charter approved by the AGM on April 28, 2023
«
‹
1
2
3
4
5
6
7
8
9
10
›
»